![Dallan Murray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dallan Murray
Corporate Officer/Principal chez
VOR BIOPHARMA INC.
Fortune : 567 682 $ au 31/07/2026
Profil
Dallan Murray is currently Chief Commercial Officer at Vor Biopharma, Inc. since 2025.
Formerly, Mr. Murray was Chief Customer Officer & Executive Vice President at Sarepta Therapeutics, Inc. from 2013 to 2025.
Education includes an MBA from Queen's University and an undergraduate degree from the University of Alberta.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 08/04/2026 | 38 202 ( 0,04% ) | 567 682 $ | 31/07/2026 |
Postes actifs de Dallan Murray
| Sociétés | Poste | Début |
|---|---|---|
| VOR BIOPHARMA INC. | Corporate Officer/Principal | 04/08/2025 |
Anciens postes connus de Dallan Murray
| Sociétés | Poste | Fin |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 16/07/2025 |
Formation de Dallan Murray
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
